Phase III Trial of SGLT2 Inhibitor and Thiazolidinedione Fixed-Dose Combination vs. Monotherapy in Type 2 Diabetes Patients on Metformin

Name: Phase III Trial of SGLT2 Inhibitor and Thiazolidinedione Fixed-Dose Combination vs. Monotherapy in Type 2 Diabetes Patients on Metformin
License: Public Domain

Eurofarma Laboratorios S.A.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

type 2 diabetes mellitus (t2dm)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 152385
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.